Live Breaking News & Updates on எலெனா மேலும்

Stay updated with breaking news from எலெனா மேலும். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Hepatitis C Drugs Boost Remdesivir's Antiviral Activity Against COVID-19


Hepatitis C Drugs Boost Remdesivir’s Antiviral Activity Against COVID-19
Drugs used to treat hepatitis C render remdesivir 10 times better at inhibiting the coronavirus in cell cultures, according to new study. Illustration credit: Jenna Luecke/University of Texas at Austin.
AUSTIN, Texas Remdesivir is currently the only antiviral drug approved in the U.S. for treating COVID-19 patients. In a paper published this week in
Cell Reports, researchers from The University of Texas at Austin, Rensselaer Polytechnic Institute (RPI) and the Icahn School of Medicine at Mount Sinai showed that four drugs used to treat hepatitis C render remdesivir 10 times better at inhibiting the coronavirus in cell cultures. ....

United States , Balasubramanian Harish , Kris White , Thomas Kehrer , Thomasb Acton , Gaetano Montelione , Adolfo Garc , Helena Moreno , Theresaa Ramelot , Catherine Royer , Khushboo Bafna , Robertm Krug , Romel Rosales , University Of Texas At Austin , Icahn School Of Medicine At Mount Sinai , Defense Advanced Research Projects Agency , Department Of Defense , National Institute Of Allergy , National Institutes Of Health , Rensselaer Polytechnic Institute , Cell Reports , Icahn School , Mount Sinai , Lisa Miorin , National Institutes , Computational Innovations ,